• Link to X
  • Hi,
  • Member Dashboard
  • Log Out
  • Contact
Grasp Cancer
  • About
    • What We Do
    • For Researchers
    • For Advocates
    • Our Team
    • Board of Advisors
  • Join Us
  • Events
  • News
  • Login
  • Donate
  • Menu Menu
  • About
    • What We Do
    • For Advocates
    • For Researchers
    • Our Team
    • Board of Advisors
  • Events
  • Join Us
  • News
  • Contact
  • Member Dashboard
  • Log In
  • Log Out
  • Donate

ASCO26 Group 5D: Advancing Melanoma Care: Innovation, Access, and Outcomes

ASCO26 Group 4E: Innovation and Real-World Outcomes in Cholangiocarcinoma Research

ASCO26 Group 2E: Beyond Treatment: Outcomes and Quality of Life in Lung Cancer Care

ASCO26 Group 5C: Curative-Intent and ADC Approaches in HER2+ Breast Cancer

ASCO26 Group 5B: Treatment Strategies for Brain Metastases in HER2+ Breast Cancer

ASCO26 Group 4D: Should We Screen for Brain Metastases Earlier?

ASCO26 Group 4C: New Vaccine Approaches for Triple-Negative Breast Cancer

ASCO26 Group 4B: Biomarkers and Treatment Response in HR+ Breast Cancer

ASCO26 Group 3C: Listening to Patients: PROs and Partnership in Cancer Research

ASCO26 Group 3B: Tracking Cancer Through ctDNA Blood Tests

Page 1 of 212

GUIDING RESEARCHERS & ADVOCATES TO SCIENTIFIC PARTNERSHIPS

  • What We Do
  • For Researchers
  • For Advocates
  • Our Team
  • Board of Advisors
  • Donate
@2026 Grasp Cancer | All rights reserved. | Site by Dot Think
  • Link to X
Scroll to top Scroll to top Scroll to top